Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study.
Pantzaris MC, Bakirtzis C, Grigoriadis N, Hadjigeorgiou G, Dardiotis E, Loucaides G, Ntzani E, Markozannes G, Omorfos S, Valsasina P, Messina R, Preziosa P, Rocca MA, Patrikios I. Pantzaris MC, et al. Among authors: valsasina p. BMJ Neurol Open. 2022 Nov 4;4(2):e000334. doi: 10.1136/bmjno-2022-000334. eCollection 2022. BMJ Neurol Open. 2022. PMID: 36353267 Free PMC article.
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.
Rovaris M, Gallo A, Valsasina P, Benedetti B, Caputo D, Ghezzi A, Montanari E, Sormani MP, Bertolotto A, Mancardi G, Bergamaschi R, Martinelli V, Comi G, Filippi M. Rovaris M, et al. Among authors: valsasina p. Neuroimage. 2005 Feb 15;24(4):1139-46. doi: 10.1016/j.neuroimage.2004.10.006. Epub 2004 Nov 26. Neuroimage. 2005. PMID: 15670691 Clinical Trial.
163 results